Answers are grounded in this paper and cite their sources.
BDNF may represent a beneficial therapeutically agent against a variety of neurological and psychiatric disorders, but bad pharmacokinetics complicate its clinical use. This article focuses on the design and BDNF-like biological properties of low-molecular weight dimeric dipeptide mimetics of BDNF free of these disadvantages.
No takes yet. Share an insight, caveat, or question.
Т. А. Гудашева (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: